Back to Newsroom
Back to Newsroom

Baxter Intl., CareFusion, Mindray Medical Intl., and Unilife Under StockCall’s Microscope

Wednesday, 24 April 2013 08:55 AM

Topic:
 

StockCall.com Provides Stock Research onBaxter Intl., CareFusion, Mindray Medical Intl., and Unilife

 

New York City, New York -- (April 24, 2013)

Medical instruments & supplies companies have vehemently opposed some of the features of President Obama’s Affordable Care Act (ACA). The ACA, which was upheld by the Supreme Court last year, is expected to be beneficial to the healthcare industry in the long-term. However, in the near-term, the reform is likely to result in higher costs for the industry. Costs for medical instruments & supplies companies such as Baxter International Inc. (NYSE: BAX), CareFusion Corporation (NYSE: CFN), Mindray Medical International Ltd. (NYSE: MR), and Unilife Corp. (NASDAQ: UNIS) are expected to rise significantly as they are required to pay a 2.3% tax on U.S. gross sales. Shares of medical instruments & supplies companies ended mostly higher on Tuesday, tracking gains in the broad market. StockCall has released full comprehensive research on BAX, CFN, MR, and UNIS and these free technical analyses can be downloaded by signing up at

www.stockcall.com/technicalanalysis

Baxter International Inc.’s shares edged higher on Tuesday. The stock closed 1.04% higher at $69.85 on above average volume of 4.40 million after touching an intra-day high of $70.17. The company’s shares are currently trading close to their 52-week high of $72.85. The stock has gained nearly 5.50% so far in 2013 as compared to a gain of nearly 10.70% for the S&P 500. Shares of BAX recently crossed above their 50-day moving average, which is a bullish signal. The positive trend is further confirmed by recent volume activity. Free technical analysis on BAX available by signing up at

www.StockCall.com/BAX042413.pdf

Shares of CareFusion Corporation rose in yesterday’s trading session. The stock closed 0.79% higher at $34.28 on above average volume of 1.86 million after touching an intra-day high of $34.50. CareFusion’s shares are currently trading more than 3.70% below their 52-week high. The stock has outperformed the S&P 500 so far in 2013, gaining nearly 20%. The company’s shares have seen a series of highs since the start of this year. The stock is also trading above its 50-day and 200-day moving averages. However, its MACD chart is indicating that market sentiment has turned bearish. Register today and access the free research on CFN at

www.StockCall.com/CFN042413.pdf

Shares of Mindray Medical International Ltd’s shares rose sharply on Tuesday, extending their gains from previous trading sessions. The stock rose to an intra-day high of $39.45 before finishing the day 1.97% higher at $39.43 on above average volume of 576,290, taking its gains in the last three sessions to nearly 6.70%. Mindray Medical’s shares have seen a series of highs over the last few days of trading, which is a bullish signal. This upbeat trend is further confirmed by the stock’s MACD chart. The company’s shares face resistance at around $40. The free report on MR can be downloaded by signing up now at

www.StockCall.com/MR042413.pdf

Shares of Unilife Corp. rallied in yesterday’s trading session. The stock touched an intra-day high of $2.02 before finishing the day 2.04% higher at $2 on volume of 304,760. Despite the gains on Tuesday, Unilife’s shares have fallen nearly 11.90% thus far this year, underperforming the broad market. The stock is currently trading more than 61.30% below its 52-week high. Free report on UNIS can be accessed by registering at

www.StockCall.com/UNIS042413.pdf

 

 

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com 

  

Contact Person:

William T. Knight

Email: [email protected]

Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)

Topic:
Back to newsroom
Back to Newsroom
Share by: